The Patient brings new perspective

Share this article:
Wolters Kluwer is launching The Patient, a quarterly journal that will look at reimbursement issues from a patient perspective.

“We're trying to change the world from one that says ‘no' to medical innovation to one that says, ‘Well, what does the patient think?'” says editor John F. P. Bridges, PhD, of Johns Hopkins Bloomberg School of Public Health. Bridges says formularies, governments and others making decisions about drug access need to break out of the cost-effectiveness model as an exclusive means of determining the value of a medication. The title, intended to complement PharmacoEconomics, will launch in the fourth quarter.

Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...